Ado-Trastuzumab Emtansine Biosimilar - Research Grade

Human

HER2

1.0 - 5.0 mg/ml

Human IgG1

Humanized

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human HER2. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ado-trastuzumab emtansine.

Blue ice

An oncogenic receptor tyrosine kinase, HER2 (ERBB2) has long been a target for antibody and conjugate research. This research-grade reagent is an unconjugated, non-therapeutic analog of ado-trastuzumab emtansine, built around the HER2 target and intended strictly for research use only. Manufactured to in vivo standards as an ultra-pure, low-endotoxin human IgG1, it is supplied in scalable milligram to gram quantities to support high-throughput and bulk laboratories. The reagent is suited to preclinical applications such as HER2-binding and internalisation studies, in vitro screening, in vivo tumour models, and antibody-drug conjugate development.

Receptor tyrosine-protein kinase erbB-2, MLN 19, HER2, HER2/neu

P04626

ICH3001-100ml ICH3002-100ml ICH3003-100ml

https://www.imgt.org/mAb-DB/